Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zevra Therapeutics Inc
Net Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Net Income
-$65.8m
CAGR 3-Years
-77%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Income
$14.7B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Net Income
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Net Income
-$2.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Income
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Net Income
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
1%
CAGR 10-Years
12%

See Also

What is Zevra Therapeutics Inc's Net Income?
Net Income
-65.8m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Net Income amounts to -65.8m USD.

What is Zevra Therapeutics Inc's Net Income growth rate?
Net Income CAGR 5Y
-9%

Over the last year, the Net Income growth was -102%. The average annual Net Income growth rates for Zevra Therapeutics Inc have been -77% over the past three years , -9% over the past five years .

Back to Top